Assessing the risks and benefits of treating Helicobacter pylori infection - PubMed (original) (raw)

Assessing the risks and benefits of treating Helicobacter pylori infection

Ivan F N Hung et al. Therap Adv Gastroenterol. 2009 May.

No abstract available

PubMed Disclaimer

Similar articles

• Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection.
  Hunt R, Fallone C, Veldhuyzan van Zanten S, Sherman P, Smaill F, Flook N, Thomson A; CHSG 2004 participants. Hunt R, et al. Can J Gastroenterol. 2004 Sep;18(9):547-54. doi: 10.1155/2004/326767. Can J Gastroenterol. 2004. PMID: 15457293 Review.
• Symposium: Helicobacter pylori and clinical risks--focus on gastro-oesophageal reflux disease.
  Malfertheiner P, O'Connor HJ, Genta RM, Unge P, Axon AT. Malfertheiner P, et al. Aliment Pharmacol Ther. 2002 Jun;16 Suppl 3:1-10. doi: 10.1046/j.1365-2036.16.s3.1.x. Aliment Pharmacol Ther. 2002. PMID: 12000312
• Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.
  Lee YC, Lin JT. Lee YC, et al. J Gastroenterol Hepatol. 2017 Jun;32(6):1160-1169. doi: 10.1111/jgh.13726. J Gastroenterol Hepatol. 2017. PMID: 28087975 Review.
• Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
  Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, Upala S. Jaruvongvanich V, et al. Mult Scler Relat Disord. 2016 May;7:92-7. doi: 10.1016/j.msard.2016.03.013. Epub 2016 Mar 30. Mult Scler Relat Disord. 2016. PMID: 27237767 Review.
• Risks and benefits of Helicobacter pylori eradication: current status.
  Hunt RH, Fallone C, Veldhuyzen van Zanten S, Sherman P, Smaill F, Thomson AB; Canadian Helicobacter Study Group. Hunt RH, et al. Can J Gastroenterol. 2002 Jan;16(1):57-62. doi: 10.1155/2002/202961. Can J Gastroenterol. 2002. PMID: 11826340 Review.

Cited by

• Helicobacter pylori infection: Beyond gastric manifestations.
  Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E Silva N, de Magalhães Queiroz DM, de Melo FF. Santos MLC, et al. World J Gastroenterol. 2020 Jul 28;26(28):4076-4093. doi: 10.3748/wjg.v26.i28.4076. World J Gastroenterol. 2020. PMID: 32821071 Free PMC article. Review.
• The Effects of Synbiotic "Bifidobacterium lactis B94 plus Inulin" Addition on Standard Triple Therapy of Helicobacter pylori Eradication in Children.
  Ustundag GH, Altuntas H, Soysal YD, Kokturk F. Ustundag GH, et al. Can J Gastroenterol Hepatol. 2017;2017:8130596. doi: 10.1155/2017/8130596. Epub 2017 Jun 1. Can J Gastroenterol Hepatol. 2017. PMID: 28656129 Free PMC article. Clinical Trial.
• Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes.
  Alebouyeh M, Yadegar A, Farzi N, Miri M, Zojaji H, Gharibi S, Fazeli Z, Ebrahimi Daryani N, Asadzadeh Aghdaei H, Zali MR. Alebouyeh M, et al. Gastroenterol Hepatol Bed Bench. 2015 Spring;8(Suppl 1):S1-5. Gastroenterol Hepatol Bed Bench. 2015. PMID: 26171132 Free PMC article. No abstract available.
• Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis.
  Gomez-Ramirez U, Valencia-Mayoral P, Mendoza-Elizalde S, Murillo-Eliosa JR, Solórzano Santos F, Contreras-Rodríguez A, Zúñiga G, Aguilar-Rodea P, Jiménez-Rojas VL, Vigueras Galindo JC, Salazar-García M, Velázquez-Guadarrama N. Gomez-Ramirez U, et al. Pathogens. 2021 Sep 16;10(9):1203. doi: 10.3390/pathogens10091203. Pathogens. 2021. PMID: 34578235 Free PMC article. Review.
• Disrupted human-pathogen co-evolution: a model for disease.
  Kodaman N, Sobota RS, Mera R, Schneider BG, Williams SM. Kodaman N, et al. Front Genet. 2014 Aug 25;5:290. doi: 10.3389/fgene.2014.00290. eCollection 2014. Front Genet. 2014. PMID: 25202324 Free PMC article.

References

1. 1. Asaka M., Sugiyama T., Nobuta A., Kato M., Takeda H., Graham D.Y. (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6:294–299 - PubMed
2. 1. Blaser M.J. (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530 - PubMed
3. 1. Chen L.T., Lin J.T., Tai J.J., Chen G.H., Yeh H.Z., Yang S.S.et al. (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 97:1345–1353 - PubMed
4. 1. Chen Y., Blaser M.J. (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 167:821–827 - PubMed
5. 1. Chen Y., Blaser M.J. (2008) Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 198:553–560 - PMC - PubMed

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central